Full Text
PHM16 PHARMACOKINETIC-PHARMACODYNAMIC-PHARMACOECONOMIC (P3) MODELING TO INFORM PHARMACOGENOMIC TRIAL DESIGN AND RISK MANAGEMENT

Abstract

Authors

DL Veenstra PH Salinger LP Garrison DD Shen P Vicini

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×